The US House of Representatives has passed the Faster Labor Contracts Act (H.R. 5408) (FLCA), a bill that would fundamentally reshape how employers negotiate first collective bargaining agreements with newly certified unions.
Earlier this year, we flagged the growing momentum behind state efforts to regulate dynamic and surveillance pricing.
States Reconsider Data Center Incentives and Permitting as Energy, Water, and Fiscal Pressures Mount
State policymakers are recalibrating how they regulate and incentivize data center development.
On June 2, the US Food and Drug Administration (FDA) released a new draft guidance called “Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing.”
The Federal Aviation Administration (FAA) and US Department of Defense have stalled project reviews.
On May 28, the US Supreme Court issued a unanimous decision in Flowers Foods, Inc. v. Brock, holding that a worker who transports goods on an intrastate leg of an interstate journey may qualify for the Federal Arbitration Act’s (FAA) transportation-worker exemption under Section 1 — even if that worker never crosses state lines and never interacts with a vehicle that does.
On June 8, the California State Senate adopted Senate Resolution (SR) 104, a measure expressing support for targeting the biological mechanisms of aging as a strategy to prevent and delay chronic disease.
The 2027 DC budget would deliver significant new funding, programs, and policy changes to rental housing across the District of Columbia, affecting all parties involved, like tenants, landlords, and developers.
US alcohol importers, and alcohol suppliers that rely on imported ingredients or raw materials to produce their products, have been on a rollercoaster during President Trump’s second term trying to keep up with the Administration’s tariff policy.
On June 3, the US Food and Drug Administration (FDA) released a revised draft guidance on what drug and device manufacturers can say to health insurers, pharmacy benefit managers (PBMs), formulary committees, and similar organizations about their products.
The 2027 DC budget proposes substantial investments in health care access, behavioral health services, and public health infrastructure across the District of Columbia. Nearly four in 10 DC residents depend on Medicaid, the Basic Health Plan, or the locally funded Alliance program for coverage.
The 2027 DC budget would make sweeping investments in education across the District of Columbia, from pre-kindergarten through higher education and adult literacy. The budget supports nearly 100,000 public and public charter school students, increases per-student funding, restores critical childcare programs at risk of deep cuts, and expands career and technical education.
The 2026 legislative cycle reveals that state privacy law is diverging along partisan lines. Red-state legislatures are pursuing frameworks that retain the Virginia architecture while easing compliance burdens through broader exemptions, narrower sale definitions, permanent cure periods, and fewer assessment requirements. Blue states are moving in the opposite direction, expanding sensitive-data categories, imposing new technology-specific obligations, and broadening applicability.
On June 2, President Trump signed an executive order (EO) entitled “Promoting Advanced Artificial Intelligence Innovation and Security” that establishes new federal cybersecurity directives, creates a voluntary framework for collaboration with artificial intelligence (AI) developers on frontier models, and signals increased focus on criminal enforcement against AI-enabled cyberattacks.
On June 4, the US Supreme Court issued a unanimous decision authored by Justice Ketanji Brown Jackson in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24–889, delivering a significant win for generic pharmaceutical manufacturers seeking US Food and Drug Administration (FDA) approval for drugs with multiple indications.
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, James G. Pizzo
Headlines that Matter for Companies and Executives in Regulated Industries
The Fourth Appellate District’s June 2 decision in Tate Road Solar 1, LLC v. County of Winnebago held that Illinois courts cannot compel counties to issue permits when solar projects meet statewide standards for solar siting under 55 ILCS 5/5-12020.
The US Departments of Treasury, Labor, and Health and Human Services have issued a sweeping final rule (CMS-9897-F) implementing significant changes to the Federal Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA).
On March 13, President Trump signed an executive order (EO) titled “Ensuring Truthful Advertising of Products Claiming to be Made in America,” directing the Federal Trade Commission (FTC) to prioritize enforcement against false or unsubstantiated “Made in USA” and similar American-origin claims.
Prop 65 Counsel: What To Know
David R. Hamill, James Kim*, Katie L. Gustafson, Mario A. Torrico, Andrew McArthur, Birgit Matthiesen
On June 3, President Trump signed an executive order (EO) titled “Strengthening Customs Enforcement” that does not impose a single new tariff yet may prove to be one of the most consequential trade actions of the year for importers.
Cissy Jackson, Kevin R. Pinkney, Shira Helstrom, Brian D. Schneider, Douglas A. Grimm, Jon S. Bouker
On May 29, the Office of Management and Budget (OMB) and over 40 federal agencies jointly issued a proposed rule that would significantly change the government-wide framework for grants and cooperative agreements and clarify that what is currently called “guidance” will, as amended, be a binding regulation.
The tariff rollercoaster continues! Late in the evening on June 2, the US Trade Representative (USTR) issued its much anticipated notice of determinations in its Section 301 investigation concerning the failure of various economies to impose and effectively enforce a prohibition on the importation of goods produced with forced labor.
Linda M. Jackson, Matthew F. Prewitt, Allan E. Anderson, Ehsun Forghany, Nicholas J. Nesgos, Alexander H. Spiegler, Meghan F. Hart, John M. Hindley, Nicole Curtis Martinez
In a 2-1 decision authored by Judge Timothy B. Dyk, the Federal Circuit reversed a jury verdict awarding Insulet Corporation over $59 million in compensatory and exemplary damages for trade secret misappropriation under the Defend Trade Secrets Act (DTSA).
On May 28, the US Environmental Protection Agency (EPA) issued a final rule that reinstates the longstanding emergency affirmative defense provision under the Clean Air Act’s Title V operating permit programs (the “Emergency AD” rule).